Division of Cardiovascular Surgery, Heart Center, Cheng Hsin General Hospital.
Division of Cardiovascular Surgery, Department of Surgery, Shuang-Ho Hospital.
Int J Surg. 2024 Feb 1;110(2):943-955. doi: 10.1097/JS9.0000000000000898.
The dermal regeneration template (DRT), a tissue-engineered skin substitute composing a permanent dermal matrix and an upper temporary silicone layer that serves as the epidermis, has demonstrated efficacy in treating uncomplicated diabetic foot ulcers (DFUs). Our institution has obtained good outcomes with DRT in patients with more complicated DFUs. Because of its chronicity, the authors are working to identify a clinical target that anticipates delayed healing early in the treatment in addition to determining the risk factors linked to this endpoint to increase prevention.
This retrospective single-center study analyzed patients with DFUs who underwent wound reconstruction using DRT between 2016 and 2021. The patients were categorized into poor or good graft-take groups based on their DRT status on the 21st day after the application. Their relationship with complete healing (CH) rate at day 180 was analyzed. Variables were collected for risk factors for poor graft take at day 21. Independent risk factors were identified after multivariable analysis. The causes of poor graft take were also reported.
This study examined 80 patients (38 and 42 patients in the poor and good graft-take groups, respectively). On day 180, the CH rate was 86.3% overall, but the poor graft-take group had a significantly lower CH rate (76.3 vs. 95.2%, P =0.021) than the good graft-take group. Our analysis identified four independent risk factors: transcutaneous oxygen pressure less than 30 mmHg (odds ratio, 154.14), off-loading device usage (0.03), diabetic neuropathy (6.51), and toe wound (0.20). The most frequent cause of poor graft take was infection (44.7%), followed by vascular compromise (21.1%) and hematoma (15.8%).
Our study introduces the novel concept of poor graft take at day 21 associated with delayed wound healing. Four independent risk factors were identified, which allows physicians to arrange interventions to mitigate their effects or select patients more precisely. DRT represents a viable alternative to address DFUs, even in complicated wounds. A subsequent split-thickness skin graft is not always necessary to achieve CH.
真皮再生模板(DRT)是一种组织工程皮肤替代物,由永久性真皮基质和上层临时硅胶层组成,充当表皮,已证明在治疗单纯性糖尿病足溃疡(DFU)方面有效。我们机构在治疗更复杂的 DFU 患者时,使用 DRT 取得了良好的效果。由于其慢性,作者正在努力确定一个临床指标,以便在治疗早期预测延迟愈合,除了确定与该终点相关的危险因素,以增加预防。
本回顾性单中心研究分析了 2016 年至 2021 年间使用 DRT 进行创面重建的 DFU 患者。根据应用后第 21 天的 DRT 状态,将患者分为差或好移植物组。分析了它们与 180 天完全愈合(CH)率的关系。收集了第 21 天差移植物成活率的危险因素变量。多变量分析后确定了独立的危险因素。还报告了差移植物成活率差的原因。
本研究共检查了 80 例患者(差和好移植物组分别为 38 例和 42 例)。180 天时,总体 CH 率为 86.3%,但差移植物组的 CH 率明显低于好移植物组(76.3%比 95.2%,P=0.021)。我们的分析确定了四个独立的危险因素:经皮氧分压<30mmHg(优势比,154.14)、减压装置使用(0.03)、糖尿病神经病变(6.51)和脚趾伤口(0.20)。差移植物成活率低的最常见原因是感染(44.7%),其次是血管损伤(21.1%)和血肿(15.8%)。
本研究提出了第 21 天差移植物成活率与延迟愈合相关的新概念。确定了四个独立的危险因素,这使得医生可以安排干预措施来减轻其影响,或更准确地选择患者。DRT 是治疗 DFU 的一种可行选择,即使是在复杂的伤口中。不一定需要随后进行分层皮片移植来实现 CH。